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Abstract
Background: Clostridium difficile infection (CDI) has increased to epidemic proportions in recent years. The carriage
of C. difficile among healthy adults and hospital inpatients has been established. We sought to determine whether
C. difficile colonization exists among healthcare workers (HCWs) in our setting.
Methods: A point prevalence study of stool colonization with C. difficile among doctors, nurses and allied health staff
at a large regional teaching hospital in Geelong, Victoria. All participants completed a short questionnaire and all stool
specimens were tested by Techlab® C.diff Quik Check enzyme immunoassay followed by enrichment culture.
Results: Among 128 healthcare workers, 77% were female, of mean age 43 years, and the majority were nursing staff
(73%). Nineteen HCWs (15%) reported diarrhoea, and 12 (9%) had taken antibiotics in the previous six weeks. Over 40%
of participants reported having contact with a patient with known or suspected CDI in the 6 weeks before the stool
was collected. C. difficile was not isolated from the stool of any participants.
Conclusion: Although HCWs are at risk of asymptomatic carriage and could act as a reservoir for transmission in the
hospital environment, with the use of a screening test and culture we were unable to identify C. difficile in the stool of
our participants in a non-outbreak setting. This may reflect potential colonization resistance of the gut microbiota, or
the success of infection prevention strategies at our institution.
Background
Clostridium difficile infection (CDI) has increased to epi-
demic proportions in recent years [1,2]. It is estimated that
approximately 20% of hospitalized adults are C. difficile
carriers who shed the bacterium in their stool [3-5]. Clin-
ical factors, such as previous C. difficile-associated disease
and recent antibiotic use may be predictive of asymptom-
atic carriage [5].
The carriage of C. difficile has been studied among inpa-
tients previously [6]. Inpatients at a large centre in Boston
were sampled for the presence of C. difficile and 18% of
admissions were positive for C. difficile at the time of ad-
mission, while a further 15% acquired the infection after
testing negative on admission. Similarly, Johnson and
others found that 21% of patients acquired C. difficile dur-
ing hospital admission, and 85% of these patients were
asymptomatic [7]. The risk of colonization increases at
a steady rate during hospitalization, suggesting a cu-
mulative daily risk of exposure to C. difficile, probably
as spores, which can persist for months in the hospital
environment [8,9].
Colonized individuals are by definition asymptomatic
and not at greater risk of developing diarrhoea [6,7]. In-
deed, colonization with non-toxigenic strains of C. difficile
is protective against the development of disease with toxi-
genic strains [7]. However, it is possible that C. difficile-col-
onized individuals are a major source of nosocomial
C. difficile contamination and infection [5,10].
In a variety of studies, the prevalence of C. difficile in
the stool of healthy asymptomatic adults has varied from
less than 2% up to 15% [8,11,12]. Carriage of a C. difficile
strain among healthy adults may be either transient or
persistent [11].
There are however several unanswered questions re-
garding CDI [13]. One of these includes the role of indi-
viduals colonized with C. difficile in the transmission of
the organism in the healthcare setting. The carriage of
C. difficile by healthcare workers (HCWs) has been
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studied previously with conflicting results. Carmelli and
others cultured the stool of healthcare workers in a non-
outbreak period, and found that none of 55 specimens
contained C. difficile [14]. In a recent study in Austria, none
of 112 HCWs was colonized with C. difficile [15]. However,
in contrast, research in Japan and The Netherlands has
found 4.3% and 13% of HCWs, respectively, were colonized
with C. difficile [12,16].
It has been assumed that HCWs are at risk of asymp-
tomatic carriage and that they too could act as a reservoir
for transmission in the hospital environment. The hands of
healthcare workers, transiently contaminated with C. diffi-
cile spores, are probably the main means by which the or-
ganism is spread during non-outbreak periods [8]. Strict
adherence to hand washing with soap and water and glove
use with changing of gloves between patient contacts, are
the most effective ways to both prevent hand contamination
with C. difficile and prevent the spread of spores [4,17,18].
Barwon Health is a large regional teaching hospital, with
a total of 921 beds. No solid organ or bone marrow trans-
plantation is performed at our institution. Prospective
laboratory-based surveillance for CDI commenced in 2010,
with cases being submitted to the Victorian Healthcare
Associated Infection Surveillance System [19,20]. Rates of
CDI at our institution in 2010 were 1.9 per 10,000 occu-
pied bed days, 3 per 10,000 occupied bed days in 2011, and
2.4 per 10,000 occupied bed days in 2012, in keeping with
the state aggregate in Victoria, Australia [20]. No seasonal-
ity of CDI had been noted at our institution.
This point prevalence study was performed in 2012 to
determine the prevalence of C. difficile stool carriage
among the major occupational groups of healthcare




HCWs from acute care, rehabilitation, and residential aged
care at our institution were invited to participate over 14
weeks in 2012. Healthcare workers who were approached
for participation included doctors, nurses, physiotherapists
and occupational therapists. Participants were consented,
and provided with a specimen collection kit and a ques-
tionnaire printed on their pathology form. Participants
were identified by a unique study identifier number. There
were no payments or incentives provided for participation
in the study, and the Human Research and Ethics Com-
mittee at Barwon Health approved this research.
Data collection
The pathology form included questions to ascertain basic
demographic data and risk factors for C. difficile acquisi-
tion. Employment location was determined through
tick boxes (Acute Hospital/Inpatient rehabilitation/
Residential aged Care). Participants indicated their pro-
fession (Doctor/Nurse/Allied Health) as well as the type
of workplace or ward (Aged Care/Emergency Department/
Intensive Care Unit/Medical ward/Obstetrics/Paediatrics/
Psychiatry/Rehabilitation/Surgical/Operating Theatre). In-
formation was also sought about antibiotic therapy, con-
tact with a patient with known or suspected CDI, and
diarrhoea or hospitalization in the preceding 6 weeks.
Participant study data identified by unique study num-
ber from the pathology request form was entered into
the study database upon arrival in the laboratory.
Microbiological methods
Faecal specimens were delivered to the microbiology la-
boratory identified only by study number. The Techlab® C.
diff Quik Check Complete test kit (Blacksburg, VA), com-
prising a dual rapid membrane enzyme immunoassay for
toxins A and B and for glutamate dehydrogenase (GDH)
antigen, was utilized for initial screening of specimens.
In accordance with product recommendations, 25 μL
of specimen was mixed to 750 μL of diluent and single
drop of conjugate before transfer to the sample well.
After incubation at room temperature for 15 min, the
membrane was washed with 300 μL of wash buffer, and
two drops of the substrate reagent was applied. The win-
dow, which contains an internal control, is read for up
to 10 min whilst incubating at room temperature.
All specimens were subsequently frozen, then batched
and forwarded to a reference laboratory in Western
Australia for C. difficile culture. Attempts to isolate C. diffi-
cile were made based on previously described methods
[21,22]. Stool samples were cultured on cycloserine cefoxitin
fructose agar (CCFA) and in an enrichment broth con-
taining gentamicin, cycloserine and cefoxitin (GCC broth).
After 48 hours incubation, 1 mL of enrichment broth was
alcohol shocked with an equal volume of absolute ethanol
for 1 hour and then plated onto CCFA containing sodium
taurocholate. All plates were incubated in an anaerobic
chamber (Don Whitley Scientific Ltd., Shipley West
Yorkshire, UK) at 37°C, in an atmosphere containing
80% nitrogen, 10% hydrogen and 10% carbon dioxide.
Putative colonies of C. difficile were identified on the
basis of their characteristic odour (horse dung smell), col-
ony morphology (yellow, ground glass appearance) and
their chartreuse fluorescence under long-wave UV light
(~360 nm). The identity of doubtful isolates was con-
firmed by Gram stain, a latex agglutination test kit (Oxoid
Ltd., Basingstoke, Hampshire, UK) [23], and the presence
of the L-proline aminopeptidase activity (Remel Inc.,
Lenexa, KS, USA).
Data analysis
Non-identifiable data was entered into an excel spread-
sheet. The continuous variable of age was described using
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the mean and range. Categorical variables were described
using numbers and percentages.
Results
A total of 214 healthcare workers were consented to par-
ticipate in this research of whom 128 provided a stool spe-
cimen for analysis. The mean age of participants was 43
years (range 21–65 years), three-quarters were female, and
most were nursing staff (Table 1). Stool provided was
formed in the majority of participants, and 15% reported
diarrhoea in the previous 6 weeks. Nearly half of the par-
ticipants reported having contact with a patient with
known or suspected CDI. One HCW of 128 (0.8%) tested
positive by toxin and GDH assay but negative on culture.
All other 127 samples tested negative by the screening
test, and by culture.
Discussion
So called hypervirulent strains of C. difficile have emerged
internationally, and more recently in Australia, and are re-
sponsible for causing hospital outbreaks with high mor-
bidity and mortality [2,20,24-26]. Between October 2010
and March 2011, 2.3% of C. difficile infections were caused
by a hypervirulent strain in Victoria, Australia [20]. This
burden of disease provides a good impetus to understand
the likely sources of C. difficile.
Colonization with C. difficile is known to occur among
patients, especially those with risk factors of previous CDI,
recent antibiotic use and exposure to the healthcare envir-
onment [5,8]. Existing research on healthcare worker
colonization with C. difficile has yielded conflicting results.
Studies published in 1998 and 2012 did not detect C. diffi-
cile stool colonization among 55 and 112 healthcare
workers, respectively [14,15]. In contrast, C. difficile
carriage was detected in 4 of 30 HCWs (13%) by van Nood,
and in 4.3% of hospital staff by Kato [12,16]. These data
indicate that colonization among HCWs typically oc-
curs at a similar frequency as colonization among
healthy adults [8,11,12], and that a large occupational
exposure would be required to result in colonization or
infection among HCWs.
Arfons and others suggest that C. difficile may be an un-
derappreciated occupational risk for healthcare workers.
Many healthcare workers are immunocompromised or
have chronic medical conditions, and antibiotic treatment
in the preceding year has been reported by nearly half of
healthcare workers [14,27]. In the present study although
9% of HCWs had taken antibiotics in the preceding six
weeks, the mean age of participants was 43 years, and they
are likely to represent a healthy adult population. Among
healthy adults the innoculum of C. difficile required to re-
sult in detection in stool is large. Villano and others evalu-
ated an oral suspension of nontoxigenic C. difficile in
healthy adults and found that this nontoxigenic strain was
found in the stool of subjects given 108 spores twice daily
[28]. The dose required for detecton in stool was still 104
spores or more daily even when vancomycin was adminis-
tered [28]. In addition, healthy adults not treated with an-
tibiotics are likely to be protected from colonization with
C. difficile by their indigenous faecal microbiota [29,30].
In the present study, healthcare workers including
doctors, nurses, physiotherapists, and occupational ther-
apists were approached for recruitment. These categor-
ies of healthcare workers were chosen because of their
direct contact with patients. Our volunteers in this point
prevalence study were predominantly female nurses as
was found in Hell’s study [15]. Of all HCW groups,
nursing staff are likely to have the closest contact with
patients and be at greatest risk of exposure to stool.
The testing used in this study included the Techlab® C.
diff Quik Check enzyme immunoassay followed by cul-
ture. Nucleic acid amplification tests can be as much as
twice as sensitive as enzyme immunoassays and can detect
C. difficile more accurately when used in populations with
an appropriate pretest probability (i.e., patients with more
than three unformed stools in a 24 hour period without
an identified cause) [31]. Enrichment culture is more sen-
sitive a method for the detection of C. difficile than nucleic
acid amplification tests [32]. It was however unclear how
these tests would perform in a population with low pretest
probability of CDI. However, given that two microbiological
methods, including enrichment culture, were used in our
study, we believe the results are likely to be accurate.
There are limitations to this study. Firstly, it is possible
that healthcare workers with heavy C. difficile exposure
may have been unlikely to participate due to fear of identi-
fication. Therefore, the healthcare workers who provided a
stool specimen may not have been a representative sample
Table 1 Characteristics of participating healthcare workers
Characteristic N (%)
Female gender 99 (77)
Mean age (range) in years 43 (21–65)
Recent antibiotic use 12 (9)
Recent diarrhoea 19 (15)
Contact with C. difficile patient 53 (41)
Recent hospitalization 1 (0.8)
Occupational group
Nursing staff 93 (73)
Medical staff 19 (15)
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of HCWs and may have been biased towards those with
no abdominal complaints, and therefore little C. difficile
exposure. In addition, our study may have been under-
powered to detect C. difficile colonization. Our initial
study size calculation assumed a population of healthcare
workers with an approximate C. difficile colonization rate
of 10% and the resultant sample size was therefore esti-
mated to be 130. Furthermore, given the stable (although
increasing) incidence of CDI at our institution, our results
may not be able to be extrapolated to other centres with a
different staff mix, patient-mix, different use of antibiotics,
and different rates of CDI.
Conclusion
With the use of a screening test and culture, we were able
to determine that colonization with C. difficile among
HCWs in our setting is rare. This may reflect potential
colonization resistance of the gut microbiota, or the suc-
cess of infection prevention strategies such as hand hy-
giene and glove use at our institution.
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